Platelet removal from human blood plasma improves detection of extracellular vesicle‐associated miRNA

Abstract Human blood plasma prepared by centrifugation contains not only extracellular vesicles (EVs) but also platelets and erythrocyte ghosts (ery‐ghosts). Here we studied whether analysis of miRNA associated with plasma EVs (EV‐miRNA) is affected by the presence of platelets and ery‐ghosts. EDTA blood was collected from healthy donors (n = 3), and plasma was prepared by the centrifugation protocol recommended by the International Society on Thrombosis and Haemostasis (ISTH), and by a centrifugation protocol from an EV‐miRNA expert lab (non‐ISTH protocol). EVs were isolated from plasma by size‐exclusion chromatography CL‐2B (SEC2B), and concentrations of platelets, activated platelets, ery‐ghosts and EVs (150–1000 nm) were measured by calibrated flow cytometry. Two EV‐associated miRNAs (let7a‐5p and miR‐21‐5p), and one platelet‐associated miRNA (miR‐223‐3p), were measured by qRT‐PCR. Measurements were performed with and without filtration using 0.8 μm track‐etched filters to remove platelets and ery‐ghosts from plasma and EV‐enriched SEC fractions. Plasma prepared by both centrifugation protocols contained platelets and ery‐ghosts, which co‐migrated with EVs into the EV‐enriched SEC2B fractions. Filtration removed platelets and ery‐ghosts (>97%; p ≤ 0.05) and did not affect the EV concentrations (p > 0.17). The miRNA concentrations were 2–4‐fold overestimated due to the presence of platelets but not ery‐ghosts. Thus, filtration of human plasma is expected to improve comparability and reproducibility of quantitative EV‐miRNA studies. Therefore, we recommend to measure and report the plasma concentration of platelets for EV‐miRNA studies, and to filter plasma before downstream analyses or storage in biobanks.

[1]  A. Hendrix,et al.  Removal of platelets from blood plasma to improve the quality of extracellular vesicle research , 2022, Journal of thrombosis and haemostasis : JTH.

[2]  O. McCarty,et al.  Irreversible alteration of extracellular vesicle and cell-free messenger RNA profiles in human plasma associated with blood processing and storage , 2022, Scientific Reports.

[3]  R. Furlan,et al.  The impact of storage on extracellular vesicles: A systematic study , 2022, Journal of extracellular vesicles.

[4]  A. Santoro,et al.  Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide , 2022, Frontiers in Immunology.

[5]  Xiaotian Zhang,et al.  miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer , 2022, Gastric Cancer.

[6]  C. Rao,et al.  Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs , 2021, PloS one.

[7]  A. Malek,et al.  A New Approach for Prostate Cancer Diagnosis by miRNA Profiling of Prostate-Derived Plasma Small Extracellular Vesicles , 2021, Cells.

[8]  N. Ngamphaiboon,et al.  Plasma extracellular vesicle microRNA‐491‐5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma , 2021, Cancer science.

[9]  D. de Jong,et al.  Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma , 2021, Journal of extracellular vesicles.

[10]  Rensheng Wang,et al.  miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma , 2021, Cancer science.

[11]  Yan Chen,et al.  Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid Biopsy , 2021, Frontiers in Molecular Biosciences.

[12]  Yun-Jie Shen,et al.  MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target , 2021, Frontiers in Cardiovascular Medicine.

[13]  Steven Wolinsky,et al.  Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients , 2020, BMC immunology.

[14]  Xinchen Sun,et al.  Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10 , 2020, Journal of experimental & clinical cancer research : CR.

[15]  A. Malek,et al.  MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules , 2020, Cells.

[16]  R. Nieuwland,et al.  Platelet removal by single-step centrifugation , 2020, Platelets.

[17]  M. Mayr,et al.  microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring , 2020, International journal of molecular sciences.

[18]  Hakho Lee,et al.  Integrated Dual‐Mode Chromatography to Enrich Extracellular Vesicles from Plasma , 2020, Advanced biosystems.

[19]  D. Issadore,et al.  A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma , 2020, Clinical Cancer Research.

[20]  J. A. Lorente Acosta,et al.  Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients , 2020, Scientific Reports.

[21]  Li Huang,et al.  Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. , 2020, Cancer letters.

[22]  Yinglong Zhang,et al.  Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma , 2020, Theranostics.

[23]  T. Schlange,et al.  Multicentric Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. , 2019, Clinical chemistry.

[24]  J. Hoffmann,et al.  Multicenter performance evaluation of the Abbott Alinity hq hematology analyzer , 2019, Clinical chemistry and laboratory medicine.

[25]  Han Liu,et al.  Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1. , 2019, International journal of oncology.

[26]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[27]  D. Koppers-Lalic,et al.  Vesicle‐bound EBV‐BART13‐3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV‐infections , 2018, International journal of cancer.

[28]  K. Witwer,et al.  miRNAs in platelet-poor blood plasma and purified RNA are highly stable: a confirmatory study , 2018, bioRxiv.

[29]  A. Llorente,et al.  Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients , 2017, BMC Cancer.

[30]  J. Simonsen What Are We Looking At? Extracellular Vesicles, Lipoproteins, or Both? , 2017, Circulation research.

[31]  M. Mayr,et al.  MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens , 2017, Circulation research.

[32]  A. Brisson,et al.  Extracellular vesicles from activated platelets: a semiquantitative cryo-electron microscopy and immuno-gold labeling study , 2017, Platelets.

[33]  D. de Jong,et al.  Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients , 2016, JCI insight.

[34]  A. Quyyumi,et al.  Platelets confound the measurement of extracellular miRNA in archived plasma , 2016, Scientific Reports.

[35]  S. Mornet,et al.  Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.

[36]  Praveen Sethupathy,et al.  HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells , 2014, Nature Communications.

[37]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[38]  E. Kroh,et al.  Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels , 2013, PloS one.

[39]  Hugh S Markus,et al.  Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.

[40]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[41]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[42]  C Briggs,et al.  Continuing developments with the automated platelet count 1 , 2007, International journal of laboratory hematology.

[43]  A. Grant,et al.  Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy , 2003, Thrombosis and Haemostasis.

[44]  P. Apel,et al.  Track etching technique in membrane technology , 2001 .

[45]  R. Raffai,et al.  Isolation of Plasma Lipoproteins as a Source of Extracellular RNA. , 2018, Methods in molecular biology.

[46]  Ramon Goni,et al.  The qPCR data statistical analysis , 2009 .